Polysorbate 80 hypersensitivity reactions: A renewed call to action

Community Oncology

Volumn 7, Issue 9, 2010, Pages 425-428

  Norris, LeAnn B ^a   Qureshi, Zaina P ^a   Brandon Bookstaver, P ^a   Raisch, Dennis W ^b   Sartor, Oliver ^c   Chen, Hao ^d   Chen, Fei ^d   Bennett, Charles L ^a,e  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d eHealthMe   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CABAZITAXEL; CREMOPHOR; DEXAMETHASONE; DEXCHLORPHENIRAMINE; DOCETAXEL; JEVTANA; PACLITAXEL; POLYSORBATE 80; PREDNISONE; RANITIDINE; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER SURVIVAL; DRUG APPROVAL; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPNEA; FOOD AND DRUG ADMINISTRATION; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; LUNG CANCER; NANOPHARMACEUTICS; PROSTATE CANCER; URTICARIA;

EID: 78549253838     PISSN: 15485315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1548-5315(11)70418-1     Document Type: Article

References (7)

1. Taxol [package insert]. Princeton, NJ: Bristol-Myers Squibb; July 2007. http:// packageinserts.bms.com/pi/pi_taxol.pdf. Accessed September 9, 2010.
2. eHealthMe Real World Drug Outcomes. http://www.ehealthme.com/. Accessed September 9, 2010.
3. Schrijvers D, Wanders J, Dirix L, et al. Coping with toxicities of docetaxel (Taxotere). Ann Oncol 1993;4:610-611.
4. Taxotere [package insert]. Bridgewater, NJ: sanofi-aventis U.S. LLC; May 2010. http:// products.sanofi-aventis.us/Taxotere/taxotere.pdf. Accessed September 9, 2010.
5. Jevtana [package insert]. Bridgewater, NJ: sanofi-aventis U.S. LLC; June 2010. http:// products.sanofi-aventis.us/jevtana/jevtana.html. Accessed September 9, 2010.
6. Irizarry LD, Luu TH, McKoy JM, et al. Cremophor EL-containing paclitaxel-induced anaphylaxis: a call to action. Commun Oncol 2009;6:132-134.
7. ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin Pharmacokinet 2003;42:665-685.